Recent progress of imaging agents for Parkinson's disease.
about
Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.Succinobucol, a Non-Statin Hypocholesterolemic Drug, Prevents Premotor Symptoms and Nigrostriatal Neurodegeneration in an Experimental Model of Parkinson's Disease.
P2860
Recent progress of imaging agents for Parkinson's disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Recent progress of imaging agents for Parkinson's disease.
@ast
Recent progress of imaging agents for Parkinson's disease.
@en
type
label
Recent progress of imaging agents for Parkinson's disease.
@ast
Recent progress of imaging agents for Parkinson's disease.
@en
prefLabel
Recent progress of imaging agents for Parkinson's disease.
@ast
Recent progress of imaging agents for Parkinson's disease.
@en
P2093
P2860
P1476
Recent progress of imaging agents for Parkinson's disease.
@en
P2093
P2860
P304
P356
10.2174/1570159X13666141204221238
P577
2014-12-01T00:00:00Z